L

Lepu Biopharma
2157

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$10.13B
EV
HK$10.50B
Shares Outstanding
1.71B
Beta
-0.11

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
HK$4.69
P/E 2025E
-
P/Revenue 2025E
19.49x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Lepu Biopharma Co., Ltd.

gainify

L

Lepu Biopharma Co., Ltd.

2157

Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for cancer targeted therapy and immunotherapy in China and internationally. The company offers PUYOUHENG (Pucotenlimab Injection), a humanized ...

Sector

Healthcare

Industry

Biotechnology

CEO

Sui, Ziye

Employees

498

IPO Date

2022-02-23

Headquarters

No. 651, Lianheng Road, Minhang District, Shanghai 201612, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.